Taxinine BCAS# 18457-44-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 18457-44-8 | SDF | Download SDF |
| PubChem ID | 10055179 | Appearance | Powder |
| Formula | C37H44O11 | M.Wt | 664.8 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(1R,2R,3R,5S,7S,8S,9R,10R)-2,7,9,10-tetraacetyloxy-8,12,15,15-tetramethyl-4-methylidene-13-oxo-5-tricyclo[9.3.1.03,8]pentadec-11-enyl] (E)-3-phenylprop-2-enoate | ||
| SMILES | CC1=C2C(C(C3(C(CC(C(=C)C3C(C(C2(C)C)CC1=O)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)OC(=O)C)C)OC(=O)C)OC(=O)C | ||
| Standard InChIKey | SLJNSLIEGINNEE-UWUOQQJISA-N | ||
| Standard InChI | InChI=1S/C37H44O11/c1-19-27(42)17-26-33(45-22(4)39)32-20(2)28(48-30(43)16-15-25-13-11-10-12-14-25)18-29(44-21(3)38)37(32,9)35(47-24(6)41)34(46-23(5)40)31(19)36(26,7)8/h10-16,26,28-29,32-35H,2,17-18H2,1,3-9H3/b16-15+/t26-,28-,29-,32-,33+,34+,35-,37+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Taxinine and taxinine B can inhibit the drug transport by P-glycoprotein in multidrug-resistant cells. 2. Taxinine B shows stronger inhibitory effects than acetylsalicylic acid (ASA) on platelet aggregation induced by arachidonic acid (AA). |
Taxinine B Dilution Calculator
Taxinine B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.5042 mL | 7.5211 mL | 15.0421 mL | 30.0842 mL | 37.6053 mL |
| 5 mM | 0.3008 mL | 1.5042 mL | 3.0084 mL | 6.0168 mL | 7.5211 mL |
| 10 mM | 0.1504 mL | 0.7521 mL | 1.5042 mL | 3.0084 mL | 3.7605 mL |
| 50 mM | 0.0301 mL | 0.1504 mL | 0.3008 mL | 0.6017 mL | 0.7521 mL |
| 100 mM | 0.015 mL | 0.0752 mL | 0.1504 mL | 0.3008 mL | 0.3761 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Bakkenolide D
Catalog No.:BCN2909
CAS No.:18456-03-6
- 1-Oxobakkenolide S
Catalog No.:BCN7114
CAS No.:18456-02-5
- Bakkenolide B
Catalog No.:BCN7207
CAS No.:18455-98-6
- Madecassic acid
Catalog No.:BCN1013
CAS No.:18449-41-7
- Gefitinib hydrochloride
Catalog No.:BCC1591
CAS No.:184475-55-6
- Gefitinib
Catalog No.:BCN2173
CAS No.:184475-35-2
- Cucurbitacin E
Catalog No.:BCN2300
CAS No.:18444-66-1
- Vitisin B
Catalog No.:BCN6697
CAS No.:142449-90-9
- Picfeltarraenin IV
Catalog No.:BCN2852
CAS No.:184288-35-5
- Dihydromorin
Catalog No.:BCN1149
CAS No.:18422-83-8
- SR 142948
Catalog No.:BCC7323
CAS No.:184162-64-9
- GB 2a
Catalog No.:BCN7425
CAS No.:18412-96-9
- 7-Deacetoxytaxinine J
Catalog No.:BCN7677
CAS No.:18457-45-9
- Taxinine J
Catalog No.:BCN6943
CAS No.:18457-46-0
- ROS 234 dioxalate
Catalog No.:BCC7245
CAS No.:184576-87-2
- Mangostanol
Catalog No.:BCN1151
CAS No.:184587-72-2
- Ethyl Coumarin-3-Carboxylate
Catalog No.:BCC9228
CAS No.:1846-76-0
- Nigracin
Catalog No.:BCN1152
CAS No.:18463-25-7
- 2-C-Methyl-D-erythrono-1,4-lactone
Catalog No.:BCN4769
CAS No.:18465-71-9
- Pelargonidin-3-O-glucoside chloride
Catalog No.:BCN3113
CAS No.:18466-51-8
- NAD 299 hydrochloride
Catalog No.:BCC6003
CAS No.:184674-99-5
- Sodium houttuyfonate
Catalog No.:BCN2978
CAS No.:1847-58-1
- Nortropacocaine
Catalog No.:BCN1889
CAS No.:18470-33-2
- Delta 5-avenasterol
Catalog No.:BCN3211
CAS No.:18472-36-1
A comparative optical aggregometry study of antiplatelet activity of taxanes from Taxus cuspidata.[Pubmed:20170941]
Thromb Res. 2010 Jun;125(6):e281-4.
Platelets are highly reactive components of the circulatory system. The cytoskeleton of a platelet is an important structure for platelet aggregation as stimulated by several agonists. An anticancer agent, taxol, has been suggested to exert platelet anti-aggregating activity by stabilizing microtubules during the aggregation process. An activity-guided fractionation was performed with a methanol extract of the leaves and twigs of Taxus cuspidata to isolate taxanes with platelet anti-aggregating effects. Compounds 1 to 7 - taxinine (1), taxinine A (2), Taxinine B (3), 2-deacetoxyTaxinine B (4), taxacin (5), taxchinin B (6), and taxol (7) - were obtained as the antiplatelet components of this plant. These taxane compounds present the possibility of securing new antiplatelet compounds which differ from currently available antiplatelet agents in chemical structure and possibly in mechanisms of action. All compounds showed stronger inhibitory effects than acetylsalicylic acid (ASA) on platelet aggregation induced by arachidonic acid (AA) (IC(50): 14.4, 64.5, 35.5, 16.0, 21.9, 28.6 and 48.2 versus 63.0microM) or U46619 (IC(50): 34.8, 24.9, 36.2, 35.0, 46.9, 71.9 and 68.7 versus 340microM). Compounds 1, 3, 4 and 5, with a cinnamoyl group at the C(5) position, showed strong inhibitory effects against AA-induced aggregation compared to compound 2 (with an -OH group at C(5)) or compounds with an oxetane ring at C(4),(5), such as compounds 6 and 7. All of the seven compounds were 5-13-fold more strongly inhibitory than ASA against U46619-induced aggregation.
